High FOXP3+ and Low KI-67 Expression as Risk Factors for Poor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer (TNBC) Reza Indri Saraswati1*, I Wayan Sudarsa2, Putu Anda Tusta Adiputra2 Abstract Background: Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options and poor prognosis. Neoadjuvant chemotherapy (NAC)